REVERSIBLE GELLING SYSTEM FOR OCULAR DRUG DELIVERY

The invention provides an ophthalmic aqueous composition for topical administration, comprising:(a) a block copolymer of propylene oxide and ethylene oxide in concentration sufficient to provide viscosity of less than about 25 centipoise at ambient temperature and viscosity of from about 25 to about...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SMERBECK, RICHARD, V, XIA, ERNING
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SMERBECK, RICHARD, V
XIA, ERNING
description The invention provides an ophthalmic aqueous composition for topical administration, comprising:(a) a block copolymer of propylene oxide and ethylene oxide in concentration sufficient to provide viscosity of less than about 25 centipoise at ambient temperature and viscosity of from about 25 to about 55 centipoise when applied topically to a patient;(b) hydroxypropyl methylcellulose in concentration sufficient to improve the durability of the gel formed by the block copolymer.The invention further provides a method for administering ophthalmic pharmaceuticals. L'invention concerne une composition ophtalmique aqueuse pour administration topique, comportant : (a) un copolymère bloc d'oxyde de propylène et d'oxyde d'éthylène en concentration suffisante pour présenter une viscosité inférieure à environ 25 centipoises, à température ambiante, et une viscosité d'environ 25 à environ 55 centipoises lorsqu'il est appliqué topiquement à un patient ; (b) de la méthylcellulose hydroxypropyle en concentration suffisante pour améliorer la durabilité du gel formé par le copolymère bloc. L'invention concerne également un procédé d'administration de médicaments ophtalmiques.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO0245683A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO0245683A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO0245683A23</originalsourceid><addsrcrecordid>eNrjZDAKcg1zDQr2dPJxVXB39fHx9HNXCI4MDnH1VXDzD1Lwdw71cQxScAkKdVdwcfXxBKqN5GFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8eH-BkYmpmYWxo5GxkQoAQBErSa6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>REVERSIBLE GELLING SYSTEM FOR OCULAR DRUG DELIVERY</title><source>esp@cenet</source><creator>SMERBECK, RICHARD, V ; XIA, ERNING</creator><creatorcontrib>SMERBECK, RICHARD, V ; XIA, ERNING</creatorcontrib><description>The invention provides an ophthalmic aqueous composition for topical administration, comprising:(a) a block copolymer of propylene oxide and ethylene oxide in concentration sufficient to provide viscosity of less than about 25 centipoise at ambient temperature and viscosity of from about 25 to about 55 centipoise when applied topically to a patient;(b) hydroxypropyl methylcellulose in concentration sufficient to improve the durability of the gel formed by the block copolymer.The invention further provides a method for administering ophthalmic pharmaceuticals. L'invention concerne une composition ophtalmique aqueuse pour administration topique, comportant : (a) un copolymère bloc d'oxyde de propylène et d'oxyde d'éthylène en concentration suffisante pour présenter une viscosité inférieure à environ 25 centipoises, à température ambiante, et une viscosité d'environ 25 à environ 55 centipoises lorsqu'il est appliqué topiquement à un patient ; (b) de la méthylcellulose hydroxypropyle en concentration suffisante pour améliorer la durabilité du gel formé par le copolymère bloc. L'invention concerne également un procédé d'administration de médicaments ophtalmiques.</description><edition>7</edition><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020613&amp;DB=EPODOC&amp;CC=WO&amp;NR=0245683A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020613&amp;DB=EPODOC&amp;CC=WO&amp;NR=0245683A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SMERBECK, RICHARD, V</creatorcontrib><creatorcontrib>XIA, ERNING</creatorcontrib><title>REVERSIBLE GELLING SYSTEM FOR OCULAR DRUG DELIVERY</title><description>The invention provides an ophthalmic aqueous composition for topical administration, comprising:(a) a block copolymer of propylene oxide and ethylene oxide in concentration sufficient to provide viscosity of less than about 25 centipoise at ambient temperature and viscosity of from about 25 to about 55 centipoise when applied topically to a patient;(b) hydroxypropyl methylcellulose in concentration sufficient to improve the durability of the gel formed by the block copolymer.The invention further provides a method for administering ophthalmic pharmaceuticals. L'invention concerne une composition ophtalmique aqueuse pour administration topique, comportant : (a) un copolymère bloc d'oxyde de propylène et d'oxyde d'éthylène en concentration suffisante pour présenter une viscosité inférieure à environ 25 centipoises, à température ambiante, et une viscosité d'environ 25 à environ 55 centipoises lorsqu'il est appliqué topiquement à un patient ; (b) de la méthylcellulose hydroxypropyle en concentration suffisante pour améliorer la durabilité du gel formé par le copolymère bloc. L'invention concerne également un procédé d'administration de médicaments ophtalmiques.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAKcg1zDQr2dPJxVXB39fHx9HNXCI4MDnH1VXDzD1Lwdw71cQxScAkKdVdwcfXxBKqN5GFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8eH-BkYmpmYWxo5GxkQoAQBErSa6</recordid><startdate>20020613</startdate><enddate>20020613</enddate><creator>SMERBECK, RICHARD, V</creator><creator>XIA, ERNING</creator><scope>EVB</scope></search><sort><creationdate>20020613</creationdate><title>REVERSIBLE GELLING SYSTEM FOR OCULAR DRUG DELIVERY</title><author>SMERBECK, RICHARD, V ; XIA, ERNING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO0245683A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2002</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SMERBECK, RICHARD, V</creatorcontrib><creatorcontrib>XIA, ERNING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SMERBECK, RICHARD, V</au><au>XIA, ERNING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>REVERSIBLE GELLING SYSTEM FOR OCULAR DRUG DELIVERY</title><date>2002-06-13</date><risdate>2002</risdate><abstract>The invention provides an ophthalmic aqueous composition for topical administration, comprising:(a) a block copolymer of propylene oxide and ethylene oxide in concentration sufficient to provide viscosity of less than about 25 centipoise at ambient temperature and viscosity of from about 25 to about 55 centipoise when applied topically to a patient;(b) hydroxypropyl methylcellulose in concentration sufficient to improve the durability of the gel formed by the block copolymer.The invention further provides a method for administering ophthalmic pharmaceuticals. L'invention concerne une composition ophtalmique aqueuse pour administration topique, comportant : (a) un copolymère bloc d'oxyde de propylène et d'oxyde d'éthylène en concentration suffisante pour présenter une viscosité inférieure à environ 25 centipoises, à température ambiante, et une viscosité d'environ 25 à environ 55 centipoises lorsqu'il est appliqué topiquement à un patient ; (b) de la méthylcellulose hydroxypropyle en concentration suffisante pour améliorer la durabilité du gel formé par le copolymère bloc. L'invention concerne également un procédé d'administration de médicaments ophtalmiques.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO0245683A2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title REVERSIBLE GELLING SYSTEM FOR OCULAR DRUG DELIVERY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T18%3A45%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SMERBECK,%20RICHARD,%20V&rft.date=2002-06-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO0245683A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true